Not really.The 1c return is based on net proceeds of ca. $6MM but does not take into consideration the costs of winding up the company.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025